|
⚲
|
| Keyboard |
| Mitchell Bloom | |
|---|---|
| Firm | |
| Address | 315 West 36th Street New York, NY 10018 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Axon Therapies Inc | 021-332379 | Executive Officer | 75.0 M of 150.0 M |
||
| Axon Therapies Inc | 021-289607 | Executive Officer | 1.3 M of 2.0 M |
||
| Axon Therapies Inc | 021-261599 | Executive Officer | 2.0 M of 2.0 M |
||
| Mevion Medical Systems Inc | 021-245473 | Executive Officer | 58.8 M | ||
| Voyager Therapeutics Inc | 021-238528 | Executive Officer | 60.0 M | ||
| Naurex Inc | 021-229372 | Executive Officer | 80.0 M | ||
| Naurex Inc | 021-217398 | Executive Officer | 25.0 M | ||
| Edimer Pharmaceuticals Inc | 021-200941 | Executive Officer | 9.8 M of 18.0 M |
||
| Naurex Inc | 021-188867 | Executive Officer | 38.0 M of 38.0 M |
||
| Zafgen Inc | 021-187910 | Executive Officer | 21.8 M | ||
| Zafgen Inc | 021-183316 | Executive Officer | 3.0 M | ||
| Coridea NC1 Inc | 021-179426 | Executive Officer | 5.0 M of 10.0 M |
||
| Ember Therapeutics Inc | 021-170448 | Executive Officer | 3.2 M of 34.2 M |
||
| RANA Therapeutics Inc | 021-169407 | Executive Officer | 2.7 M of 20.7 M |
||
| Selventa Inc | 021-169318 | Executive Officer | 5.0 M | ||
| Zafgen Inc | 021-162666 | Executive Officer | 6.1 M | ||
| Naurex Inc | 021-160088 | Executive Officer | 11.0 M | ||
| Coridea NC1 Inc | 021-152096 | Executive Officer | 3.0 M of 3.0 M |
||
| Zafgen Inc | 021-94401 | Executive Officer | 8.1 M of 10.1 M |
||
| Afferent Pharmaceuticals Inc | 021-135875 | Executive Officer | 3.0 M of 23.0 M |
||
| Ninepoint Medical Inc | 021-135073 | Executive Officer | 5.2 M of 33.2 M |
||
| Naurex Inc | 021-132513 | Executive Officer | 1.1 M | ||